Qualis Innovations, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QLIS research report →
About the company
Qualis Innovations, Inc. (QLIS) specializes in the creation, manufacturing, and distribution of solutions primarily targeting pain management and other disorders affecting the central nervous system (CNS). The company's flagship product is SOLACE, an advanced, non-invasive medical device.
- CEO
- Patrick S. Adams CFA
- IPO
- 2007
- HQ
- Chadds Ford, PA, US
Price Chart
- Market Cap
- $5.45M
- P/E
- -203.39
- P/S
- 36.25
- P/B
- 37.57
- EV/EBITDA
- -1553.65
- Div Yield
- 0.00%
- Gross Margin
- 94.63%
- Op Margin
- -6.86%
- Net Margin
- -12.50%
- ROE
- -16.82%
- ROIC
- -4.68%
- Revenue
- $221.76K · 0.00%
- Net Income
- $-492,748 · -390.37%
- EPS
- $-0.02 · -300.00%
- Op Income
- $-501,079
- FCF YoY
- -193.37%
- 52W High
- $0.94
- 52W Low
- $0.26
- 50D MA
- $0.27
- 200D MA
- $0.28
- Beta
- -2.76
- Avg Volume
- 33
Get TickerSpark's AI analysis on QLIS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our QLIS coverage
Recent articles, reports, and earnings notes.
No research on QLIS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate QLIS report →Similar companies
Peers in the same neighborhood.